Apple Watch Glucose Tracker Reaches Proof-Of-Concept

Apple reached the proof-of-concept stage of noninvasive blood glucose monitoring technology.

Image credit: Sabina, Unsplash

Apple has reached the proof-of-concept stage for sensor technology that could ultimately allow Apple Watch wearers with diabetes to monitor their blood sugar levels, according to a Bloomberg report. A few unnamed insiders who were familiar with the incredibly covert project - referred to within the firm as E5 - were quoted in Bloomberg's report. The sources claimed that after more than a decade of development, E5 has lately achieved "important milestones" that have given Apple hope for the viability of the technology in the marketplace.

Apple declined to reply to requests for comment from Fierce Medtech and declined to comment on the Bloomberg report. According to the article, Apple is now developing an iPhone-sized prototype that may be attached to a person's bicep. If Apple were to include it in a future Apple Watch, it would need to be substantially smaller.

The source claims that TSMC has been charged with developing the core chip for the sensor, which will be used in Apple's glucose tracker.

Read more: DarioHealth to Integrate Dexcom CGM Data

“Apple is taking a different approach, using a chip technology known as silicon photonics and a measurement process called optical absorption spectroscopy. The system uses lasers to emit specific wavelengths of light into an area below the skin where there is interstitial fluid - substances that leak out of capillaries - that can be absorbed by glucose. The light is then reflected back to the sensor in a way that indicates the concentration of glucose. An algorithm then determines a person’s blood glucose level.”

Diabetics would be better able to identify the meals that are elevating their blood sugar levels if glucose levels were continuously and non-invasively monitored. Using that information, they might change their diet to maintain a steady blood sugar level.

The news weighed on shares of diabetes technology companies on Wednesday, with both Dexcom and Abbott falling more than 3% before recovering. Apple gained 0.3% to $148.91 by the close in New York, the Bloomberg report said.

Sam Draper
March 17, 2023

Innovation of the Month

Do you want to discover more, visit the website
Visit Website

Other news

MediaTek’s Dimensity 1000 5G Chipset Delivers Ultra-Fast Speed and Seamless Connectivity

Taiwan-based MediaTek unveiled Dimensity, the company’s family of powerful 5G system-on...

Mojo Vision Unveils Augmented Reality Contact Lens Prototype

Mojo Vision announced its most advanced prototype of Mojo Lens.

OMRON Urging All U.S. Adults to Monitor Blood Pressure Regularly In Response To Surgeon General’s Call

OMRON Healthcare is urging regular blood pressure monitoring for all U.S. adults in response to...

WTEU19: These Companies Want to Revolutionize Healthcare with Their Smart Wearables

Healtcare now has more access to patient data.
Discover more